The SARS-CoV-2 spike protein primes inflammasome-mediated interleukin-1- beta secretion in COVID-19 patient-derived macrophages
Sebastian J. Theobald(University of Cologne), Jan Rybniker(University of Cologne), Jakob J Malin(University of Cologne), Ute Sandaradura de Silva(University of Cologne), Jessica Gräb(University of Cologne), Christoph Kreer(University of Cologne), Alexander Simonis(University of Cologne), Hamid Kashkar(University of Cologne), Boris Böll(University Hospital Cologne), Gerd Fätkenheuer(University of Cologne), Clara Lehmann(University of Cologne), Oliver A. Cornely(University of Cologne), Sandra Winter(University of Cologne), Michael Hallek(University of Cologne), Marie‐Christine Albert(University of Cologne), Isabelle Suárez(University of Cologne), Florian Klein(University of Cologne), Norma Jung(University of Cologne), Matthias Zehner(University of Cologne), Julia Fischer(German Primate Center), Philipp Köhler(University Hospital Cologne), Henning Gruell(University of Cologne)
Cited by 19
Related Papers
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k